{"cdcTestId":"2021-0012","testcaseName":"Dose #2 of the Novavax Covid-19 vaccine administered at an interval of 14 days.","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test Type","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1988-10-05T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-05T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-09T00:00:00","recommendedDate":"2022-11-09T00:00:00","pastDueDate":"2022-12-13T00:00:00"},"doses":[{"dateAdministered":"2022-10-05T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Novavax COVID-19 Vaccine","cvx":"211","mvx":"NVX","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}],"dateAdded":"2021-08-22T20:00:00","dateUpdated":"2022-07-22T12:42:46.823","generalDescription":"This test case describes when an adult is administered the second dose of the Novavax Covid-19 vaccine at an interval of 14 days after the first dose, that the dose is not valid.  Another dose should be forecast.","changedInVersion":"4.25","reasonForChange":"v4.25 -  Updated test case to align with the current Interim Clinical Considerations on 07/20/2022 concerning the use of the Novavax Covid-19 vaccine.\nv4.20 - Updated test case to align with Interim Clinical Considerations for \u0022People who received Covid-19 vaccine as part of a clinical trial\u0022 by forecasting a third dose."}